NURISE

Details for Australian Trade Mark No. 1111092 (hide)

Owner Warner-Lambert Company LLC a Delaware limited liability company

Convention US 10 February 2006 78/811851

Service Spruson & Ferguson

Various Convention priority claimed: 10 February 2006, United States of America, No. 78/811851 in respect of PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE, CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS, NEUROLOGICAL DISORDERS, UROGENITAL

Filing Date 28 April 2006

Classes

Class 5 Pharmaceutical preparations; pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations, ophthalmological preparations and premenstrual syndrome disorders, pharmaceutical sleep-aid preparations

Event Publications

11 May 2006 Application filed

3 August 2006 Application Accepted

30 November 2006 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1111093-INSULEX

1111091